Stem cell biotech BioCardia drops $50M IPO – FierceBiotech
FierceBiotech |
Stem cell biotech BioCardia drops $50M IPO
FierceBiotech A new week, another ditched IPO as BioCardia fails to find enough interest in its regenerative heart failure candidate in a tough financial market. The San Carlos, CA-based BioCardia had last summer filed a public offering designed to raise around $50 … |
